Zacks: Analysts Anticipate Mylan N.V. (MYL) Will Announce Earnings of $1.19 Per Share
Equities analysts expect that Mylan N.V. (NASDAQ:MYL) will report $1.19 earnings per share (EPS) for the current quarter, according to Zacks. Three analysts have made estimates for Mylan N.V.’s earnings, with estimates ranging from $1.12 to $1.33. Mylan N.V. reported earnings of $1.16 per share during the same quarter last year, which indicates a positive year over year growth rate of 2.6%. The firm is scheduled to announce its next quarterly earnings report before the market opens on Wednesday, August 9th.
On average, analysts expect that Mylan N.V. will report full year earnings of $5.21 per share for the current year, with EPS estimates ranging from $5.15 to $5.28. For the next year, analysts expect that the company will report earnings of $5.70 per share, with EPS estimates ranging from $5.35 to $6.00. Zacks’ EPS averages are an average based on a survey of sell-side analysts that follow Mylan N.V..
Mylan N.V. (NASDAQ:MYL) last issued its earnings results on Wednesday, May 10th. The company reported $0.93 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.92 by $0.01. The firm had revenue of $2.72 billion during the quarter, compared to analyst estimates of $2.81 billion. Mylan N.V. had a net margin of 4.59% and a return on equity of 23.69%. The business’s revenue was up 24.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.76 earnings per share.
MYL has been the subject of a number of research analyst reports. Deutsche Bank AG lowered their target price on Mylan N.V. from $52.00 to $51.00 and set a “buy” rating for the company in a report on Tuesday, April 18th. Royal Bank Of Canada set a $41.00 price objective on Mylan N.V. and gave the company a “hold” rating in a research note on Saturday, May 13th. Zacks Investment Research upgraded Mylan N.V. from a “sell” rating to a “hold” rating in a research note on Thursday, May 25th. ValuEngine cut Mylan N.V. from a “buy” rating to a “hold” rating in a research note on Wednesday, June 14th. Finally, BidaskClub upgraded Mylan N.V. from a “sell” rating to a “hold” rating in a research note on Thursday, June 22nd. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $50.92.
Shares of Mylan N.V. (NASDAQ MYL) traded down 5.13% during mid-day trading on Friday, hitting $32.92. 12,669,007 shares of the stock were exchanged. The company has a 50-day moving average price of $38.42 and a 200-day moving average price of $39.28. Mylan N.V. has a 12 month low of $32.77 and a 12 month high of $50.40. The stock has a market cap of $17.64 billion, a price-to-earnings ratio of 32.89 and a beta of 1.27.
In other Mylan N.V. news, President Rajiv Malik sold 25,000 shares of Mylan N.V. stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $40.00, for a total transaction of $1,000,000.00. Following the transaction, the president now owns 799,855 shares of the company’s stock, valued at $31,994,200. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Anthony Mauro sold 10,000 shares of Mylan N.V. stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $40.00, for a total value of $400,000.00. Following the transaction, the insider now directly owns 140,653 shares in the company, valued at approximately $5,626,120. The disclosure for this sale can be found here. Insiders own 0.69% of the company’s stock.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MYL. Columbus Circle Investors purchased a new position in Mylan N.V. during the first quarter valued at approximately $2,266,000. Nisa Investment Advisors LLC raised its position in Mylan N.V. by 0.7% in the first quarter. Nisa Investment Advisors LLC now owns 82,107 shares of the company’s stock valued at $3,201,000 after buying an additional 550 shares during the period. Bank of The West raised its position in Mylan N.V. by 4.9% in the first quarter. Bank of The West now owns 72,582 shares of the company’s stock valued at $2,830,000 after buying an additional 3,360 shares during the period. National Investment Services Inc. WI raised its position in Mylan N.V. by 15.8% in the first quarter. National Investment Services Inc. WI now owns 36,366 shares of the company’s stock valued at $1,418,000 after buying an additional 4,969 shares during the period. Finally, Parametrica Management Ltd purchased a new position in Mylan N.V. during the first quarter valued at approximately $870,000. 69.86% of the stock is currently owned by institutional investors.
Mylan N.V. Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with MarketBeat.com's FREE daily email newsletter.